A PDA-DTC/Cu-MnO2 nanoplatform for MR imaging and multi-therapy for triple-negative breast cancer treatment

被引：20

作者：

Hu, Xiaochun ^{[1
]}

Lu, Yonglin ^{[1
]}

Zhao, Wenrong ^{[2
]}

Sun, Menglin ^{[2
]}

Li, Ruihao ^{[1
]}

Feng, Lei ^{[1
]}

Yao, Tianming ^{[1
]}

Dong, Chunyan ^{[2
]}

Shi, Shuo ^{[1
]}

机构：

[1] Tongji Univ, Shanghai Key Lab Chem Assessment & Sustainabil, Sch Chem Sci & Engn, Breast Canc Ctr,Shanghai East Hosp,Sch Med, Shanghai, Peoples R China

[2] Nanjing Med Univ, Shanghai East Hosp, Breast Canc Ctr, Shanghai 200120, Peoples R China

来源：

CHEMICAL COMMUNICATIONS | 2021年 / 57卷 / 34期

关键词：

CHEMOTHERAPY; DISULFIRAM;

D O I：

10.1039/d1cc00987g

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Herein, a multi-functional nanoplatform (PDA-DTC/Cu-MnO2) was established, which has been employed for MR imaging-guided multi-therapy (CDT, PTT and chemotherapy) for cancer treatment. The in vitro and in vivo results confirmed that the biocompatible nanoplatform could significantly induce tumor cell death and inhibit tumor growth.

引用

收藏

页码：4158 / 4161

页数：4

相关论文

共 22 条

[1] Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity [J].

Chen, Di ;

Cui, Qiuzhi Cindy ;

Yang, Huanjie ;

Dou, Q. Ping .

CANCER RESEARCH, 2006, 66 (21) :10425-10433

[2] Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers [J].

Chen, Lv ;

Zhou, Lulu ;

Wang, Chunhui ;

Han, Yi ;

Lu, Yonglin ;

Liu, Jie ;

Hu, Xiaochun ;

Yao, Tianming ;

Lin, Yun ;

Liang, Shujing ;

Shi, Shuo ;

Dong, Chunyan .

ADVANCED MATERIALS, 2019, 31 (52)

[3] Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers [J].

Chen, Wu ;

Yang, Wen ;

Chen, Pengyu ;

Huang, Yongzhuo ;

Li, Feng .

ACS APPLIED MATERIALS & INTERFACES, 2018, 10 (48) :41118-41128

[4] Versatile Polydopamine Platforms: Synthesis and Promising Applications for Surface Modification and Advanced Nanomedicine [J].

Cheng, Wei ;

Zeng, Xiaowei ;

Chen, Hongzhong ;

Li, Zimu ;

Zeng, Wenfeng ;

Mei, Lin ;

Zhao, Yanli .

ACS NANO, 2019, 13 (08) :8537-8565

[5] Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram) [J].

Cvek, Boris .

DRUG DISCOVERY TODAY, 2012, 17 (9-10) :409-412

[6] A CD44-targeted Cu(ii) delivery 2D nanoplatform for sensitized disulfiram chemotherapy to triple-negative breast cancer [J].

Gao, Zhiguo ;

Li, Yaojia ;

Zhang, Yu ;

An, Peijing ;

Chen, Fanghui ;

Chen, Jian ;

You, Chaoqun ;

Wang, Zhifei ;

Sun, Baiwang .

NANOSCALE, 2020, 12 (15) :8139-8146

[7] Cu2+-Loaded Polydopamine Nanoparticles for Magnetic Resonance Imaging-Guided pH- and Near-Infrared-Light-Stimulated Thermochemotherapy [J].

Ge, Rui ;

Lin, Min ;

Li, Xing ;

Liu, Shuwei ;

Wang, Wenjing ;

Li, Shuyao ;

Zhang, Xue ;

Liu, Yi ;

Liu, Lidi ;

Shi, Feng ;

Sun, Hongchen ;

Zhang, Hao ;

Yang, Bai .

ACS APPLIED MATERIALS & INTERFACES, 2017, 9 (23) :19706-19716

[8] Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines [J].

Guo, Xiaoxia ;

Xu, Bing ;

Pandey, Shuchita ;

Goessl, Elisabeth ;

Brown, James ;

Armesilla, Angel L. ;

Darling, John L. ;

Wang, Weiguang .

CANCER LETTERS, 2010, 290 (01) :104-113

[9] Controlled release of anti-VEGF by redox-responsive polydopamine nanoparticles [J].

Jiang, Pengfei ;

Choi, Andrew ;

Swindle-Reilly, Katelyn E. .

NANOSCALE, 2020, 12 (33) :17298-17311

[10] PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges [J].

Khan, Mohammad A. ;

Jain, Vineet K. ;

Rizwanullah, Md. ;

Ahmad, Javed ;

Jain, Keerti .

DRUG DISCOVERY TODAY, 2019, 24 (11) :2181-2191